Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3765278014 | Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3765279018 | Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Is a | Product containing only buprenorphine and naloxone in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has manufactured dose form | Conventional release sublingual tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has precise active ingredient | Naloxone hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has basis of strength substance | Naloxone hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has precise active ingredient | Buprenorphine hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator value | 8 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) | Has basis of strength substance | Buprenorphine | true | Inferred relationship | Existential restriction modifier | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets